SAN MATEO, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...
Veritone ( (VERI) ) has released a notification of late filing.
As healthcare organizations face mounting financial and operational strain, efficiency has shifted from a long-term goal to an immediate imperative. During an episode of the Becker’s Private Equity & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results